🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to describe asenapine prescribing patterns in the Un...
Status
Completed
Location
Multiple Locations
Start Date
2013-04-01
Trial ID
NCT01498770
To evaluate the efficacy, safety and tolerance of an 12 and 26-week aripipr...
Status
Completed
Location
Asan Medical Center
Start Date
2004-10
Trial ID
NCT00304616
Treatments Being Tested
Current antipsychotic treatments of schizophrenia are only partially effect...
Status
Active Not Recruiting
Location
Dep. of Psychiatry and Psychotherapy, Central Institute of Mental Health
Start Date
2017-04-08
Trial ID
NCT02926859
Treatments Being Tested
Drugs such as amisulpride, known as antipsychotic drugs, are used to treat ...
Status
Terminated
Location
Institute of Psychiatry, Kings College London
Start Date
2012-05
Trial ID
NCT01454453
Treatments Being Tested
The purpose of this study was to investigate the effect of atypical antipsy...
Status
Unknown
Location
CHINA
Start Date
2021-05
Trial ID
NCT04446234
Treatments Being Tested
The primary objective is: * To compare the efficacy of the association val...
Status
Completed
Location
Sanofi-Aventis
Start Date
2004-05
Trial ID
NCT00126009
Treatments Being Tested
Primary Objective: To evaluate the effectiveness of amisulpride in Chinese...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2012-11
Trial ID
NCT01795183
Treatments Being Tested
The investigators developed an easy identification model to identify metabo...
Status
Completed
Location
Yu-Li Hospital
Start Date
2009-11
Trial ID
NCT00956189
Treatments Being Tested
Objective: Hyperprolactinemia(HPRL) which can result in a series of prolac...
Status
Completed
Location
Shanghai Mental Health Center
Start Date
2019-06-06
Trial ID
NCT04002258
Treatments Being Tested
This study is designed to evaluate the effects of a single dose of SEP-3638...
Status
Completed
Location
Department of Psychiatry, University of Oxford, Warneford Hospital
Start Date
2014-03
Trial ID
NCT01972711
Treatments Being Tested